Emily Cale
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Long-Term Effects of COVID-19
Papers in
-
- interferon and immune responses 2
-
- Endoplasmic Reticulum Stress and Disease 1
- Partner nations
- United Kingdom
In The Last Decade
Emily Cale
4 papers receiving 472 citations
Emily Cale's Hit Papers
Peers
Comparison fields: 5 of 68
- Infectious Diseases 231
- Neurology 92
- Critical Care and Intensive Care Medicine 20
- Immunology 61
- Obstetrics and Gynecology 13
Countries citing papers authored by Emily Cale
This map shows the geographic impact of Emily Cale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Cale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Cale more than expected).
Fields of papers citing papers by Emily Cale
This network shows the impact of papers produced by Emily Cale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Cale. The network helps show where Emily Cale may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 2 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 3 | 2023 | 83 | |
| 4 | 2023 | 56 |
About Emily Cale
Emily Cale is a scholar working on Immunology, Cell Biology, Infectious Diseases, Genetics and Insect Science, having authored 4 papers that have together received 490 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Infectious Diseases (231 citations), Neurology (92 citations), Critical Care and Intensive Care Medicine (20 citations), Immunology (61 citations) and Obstetrics and Gynecology (13 citations). Emily Cale has collaborated with scholars based in United Kingdom. Their work appears in journals such as Nature and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.